Active substance
Flurazepam
- US FDA 23
- Health Canada 2
- Safety 1
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| FLURAZEPAM HYDROCHLORIDE | 30MG; 15MG | capsule · oral | RISING | Prescription | 12 Jun 1985 |
| FLURAZEPAM HYDROCHLORIDE | 15MG | capsule · oral | CHARTWELL RX | Prescription | 30 Mar 1989 |
| FLURAZEPAM HYDROCHLORIDE | 30MG | capsule · oral | CHARTWELL RX | Prescription | 30 Mar 1989 |
| DALMANE | 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule · oral | VALEANT PHARM INTL | Discontinued | 7 Apr 1970 |
| FLURAZEPAM HYDROCHLORIDE | 15MG | capsule · oral | NOVITIUM PHARMA | Discontinued | 20 Mar 1986 |
| FLURAZEPAM HYDROCHLORIDE | 30MG | capsule · oral | NOVITIUM PHARMA | Discontinued | 20 Mar 1986 |
| FLURAZEPAM HYDROCHLORIDE | 15MG | capsule · oral | SUN PHARM INDUSTRIES | Discontinued | 4 Aug 1986 |
| FLURAZEPAM HYDROCHLORIDE | 30MG | capsule · oral | SUN PHARM INDUSTRIES | Discontinued | 4 Aug 1986 |
| FLURAZEPAM HYDROCHLORIDE | 30MG | capsule · oral | CHARTWELL RX | Discontinued | 25 Nov 1986 |
| FLURAZEPAM HYDROCHLORIDE | 15MG | capsule · oral | CHARTWELL RX | Discontinued | 25 Nov 1986 |
| FLURAZEPAM HYDROCHLORIDE | 15MG | capsule · oral | HIKMA INTL PHARMS | Discontinued | 8 Dec 1986 |
| FLURAZEPAM HYDROCHLORIDE | 30MG; 15MG | capsule · oral | HIKMA INTL PHARMS | Discontinued | 8 Dec 1986 |
| FLURAZEPAM HYDROCHLORIDE | 15MG | capsule · oral | USL PHARMA | Discontinued | 9 Jul 1987 |
| FLURAZEPAM HYDROCHLORIDE | 30MG | capsule · oral | USL PHARMA | Discontinued | 9 Jul 1987 |
| FLURAZEPAM HYDROCHLORIDE | 15MG | capsule · oral | HALSEY | Discontinued | 7 Jan 1988 |
| FLURAZEPAM HYDROCHLORIDE | 30MG | capsule · oral | HALSEY | Discontinued | 7 Jan 1988 |
| FLURAZEPAM HYDROCHLORIDE | 30MG | capsule · oral | SUPERPHARM | Discontinued | 4 Aug 1988 |
| FLURAZEPAM HYDROCHLORIDE | 30MG; 15MG | capsule · oral | RISING | Discontinued | 31 Jul 1991 |
| FLURAZEPAM HYDROCHLORIDE | 30MG | capsule · oral | PUREPAC PHARM | Discontinued | |
| FLURAZEPAM HYDROCHLORIDE | 15MG | capsule · oral | SUPERPHARM | Discontinued | |
| FLURAZEPAM HYDROCHLORIDE | 15MG | capsule · oral | WARNER CHILCOTT | Discontinued | |
| FLURAZEPAM HYDROCHLORIDE | 30MG | capsule · oral | WARNER CHILCOTT | Discontinued | |
| FLURAZEPAM HYDROCHLORIDE | 15MG | capsule · oral | PUREPAC PHARM | Discontinued |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| FLURAZEPAM | 00521698 | 15 MG | CAPSULE · ORAL | AA PHARMA INC |
| FLURAZEPAM | 00521701 | 30 MG | CAPSULE · ORAL | AA PHARMA INC |
Safety signals and safety-related labeling changes
- EMA PRAC 7 May 2026 PRAC signal: Miscarriage associated with in utero exposure to benzodiazepines (including fixed-dose combinations)
Action for MAH: update of the product information: No
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.